Purpose of review T follicular helper (Tfh) cells play a critical role as providers of B-cell help and dysfunction in Tfh/B-cell interactions can lead to autoimmunity or immunodeficiency. These observations have generated a great deal of interest in understanding how these cells are affected during HIV infection and how their functional changes might affect antibody responses.
INTRODUCTION
T follicular helper (Tfh) cells are a specialized subset of CD4 þ T cells that provides help to B cells in germinal centres [1] . These cells are necessary for germinal centre formation, immunoglobulin (Ig) class-switch recombination (CSR), somatic hypermutation (SHM) and differentiation of B cells into long-lived memory B cells and plasma cells [2] [3] [4] [5] [6] [7] [8] [9] [10] . Germinal centres are specialized structures within B-cell follicles wherein B cells undergo SHM of their Ig variable (V) region genes to achieve higher affinity against a corresponding antigen conferring greater protective efficacy and CSR of their constant Ig domain (Fc), which provides different effector potentials [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] . Due to their critical role as providers of B-cell help, there has been a great deal of interest in understanding how these cells are affected during HIV infection and how their functional changes alter antibody responses.
Tfh-cell differentiation is driven by the transcription factor Bcl-6 [21, 22] , although interferon-regulatory factor (IRF-4), B-cell activating transcription factor (BATF), musculoaponeurotic fibrosarcoma (MAF) and the recently described Ascl2 are also involved in Tfh-cell differentiation and function [1, [23] [24] [25] [26] . Tfh cells are characterized by their high level of chemokine (C-X-C motif) receptor 5 (CXCR5), inducible T-cell co-stimulator (ICOS) and programmed cell death-1 (PD-1) [6] [7] [8] [9] (described tissue resident Tfh cell subsets are summarized in Table 1 [2] [3] [4] [5] [6] [7] [8] [9] [10] . Tfh/B-cell interactions are therefore essential for the generation of efficient neutralizing and nonneutralizing antibody responses [9, 10, 15, 20, 21, 41, 42] 
Tissue resident Tfh cell subsets þ T cells [53, 54] . Although the precise mechanism by which Tfh cells could withstand HIV-mediated depletion is unknown, HIV and SIV-specific CD8 T cells appeared to locate outside germinal centres [37, 55] , which may in turn facilitate HIV/SIVinfected Tfh-cell accumulation in the follicles. Recently, a population of regulatory Qa-1-restricted CD8 T cells has been shown to localize in germinal centres and dampen Tfh cell development in mice [39] . However, their presence in human germinal centres and their role in targeting Tfh cells have not been investigated.
HIV-1 infected activated CD4 þ T cells escaping cytotoxic CD8 T cells as well as viral cytopathic effects can enter a quiescent state and thereby represent a major source of latently infected cells [56, 57] and a major obstacle for HIV eradication [56] [57] [58] [59] . Indeed, estimates for the half-life of the HIV latent reservoir in the blood indicated that it might take as long as 70 years to completely eradicate the latent reservoir in the presence of fully suppressive antiretroviral therapy (ART) [60] . Pioneer studies demonstrated that latently infected cells are relatively rare with a frequency of about 1 in 10 6 resting CD4 þ T cells with no significant difference observed between blood and lymph nodes [56, 61] . These observations led to the conclusion that cells from peripheral blood could be appropriately used to study the HIV latent reservoir. Using this strategy, Chomont et al. [62] have identified central memory (defined by the CD45RA
þ T cells as major cellular compartments of the latent HIV-1 reservoir in blood. However, lymphoid organs contain about 98% of the total body lymphocytes [56] , which are phenotypically and functionally distinct from CD4 þ T-cell populations circulating in the blood [6] . Therefore, studying HIV-1 latently infected lymph node memory CD4 þ T-cell populations might enable the identification of new cellular compartments that may contribute to the latent reservoir and help in the discovery of new targets for HIV-1 eradication. In this context, the group of J. Wing is currently investigating the cellular subtype distribution of HIV-1 DNA contained in blood and lymphoid tissues collected from ART-treated HIV-infected individuals and showed that effector memory þ T-cell reservoirs in the blood and lymph nodes and their relationship to each other remain to be established and will contribute to efforts in finding targets for a potential cure.
T FOLLICULAR HELPER CELL FUNCTIONAL ALTERATIONS DURING HIV INFECTION
Although HIV-1 infection elicits robust antibody responses to envelope proteins (gp120 and gp41) [63, 64] , only 10-30% of HIV-infected individuals generate potent bNAbs [65] [66] [67] [68] [69] . This relative inefficiency to generate bNAbs is partially attributed to HIV-1 structure, which harbours numerous mechanisms of humoral evasion such as sequence variable loops [70] , glycosylation [71] and conformational masking of receptor-binding sites [72] and by the fact that HIV-infected individuals develop lymphadenopathies associated with damages to follicular structures likely affecting B-cell differentiation and affinity maturation [73, 74] . Notably, the aforementioned morphological modifications have also been associated with Ig and B-cell abnormalities during the course of HIV infection [73] . Numerous B-cell perturbations appear during HIV infection, and although many of these defects are improved by ART, B-cell responses to HIV-specific antigens are diminished [75] [76] [77] [78] [79] [80] [81] .
Due The recent identification of follicular regulatory T (Tfr) cells that can migrate into follicles and restrain Tfh-cell differentiation represents another level of regulation in lymphoid tissues that could affect Tfh-cell function and B-cell responses during HIV infection [82] [83] [84] [85] [86] . Their mechanism of action is unknown, but studies in mice indicated that in the absence of PD-1 and PD-L1, these cells expanded and inhibited Tfh-cell function [87] . In a PD-1/ PD-L1 deregulated environment such as the one in HIV-infected lymph nodes, the function of these cells might be reduced leading to an expansion of Tfh cells.
A better understanding of Tfh/GC B-cell interactions will have important implications for the generation of robust HIV-specific B cell responses and for the generation of de-novo humoral responses to infections or vaccination. Clearly, the amount of data currently available are very limited and further investigation on the impact of HIV infection on Tfh-mediated B-cell help is required. A better understanding of the mechanisms that are affected by HIV infection leading to defective Tfh-cell signalling and B-cell responses could provide a critical framework for the development of novel therapeutics and vaccines and could also shed some light on the mechanisms responsible for the failure in the majority of HIV-infected individuals to produce bNAbs and their diminished responses to immunization [88] [89] [90] .
CIRCULATING MEMORY T FOLLICULAR HELPER CELLS
The fate and commitment of Tfh cells is still incompletely understood [91] [92] [93] [94] [95] . Indeed, using a mouse model of acute lymphocytic choriomeningitis virus (LCMV) infection, Hale et al. [91] showed that both LCMV-specific memory CD4 þ T cells with Tfh and Th1 commitment were generated. By using an IL-21 reporter mouse system, Luthje et al. [93] showed that Tfh cells gave rise to Tfh-like memory cells that could differentiate into conventional effector T helper cells or Tfh cells upon antigen recall. Additional studies showed that Tfh cells could revert in long-lived memory Tfh cells expressing low levels of Bcl6, CXCR5 and PD-1 expression in the absence of antigen [92, 95] . Choi et al. [96] also confirmed the capacity of Tfh cells to form memory and showed that Tfh cells shared phenotypic characteristics with memory precursor CD8 T cells. Overall, these studies demonstrated that at least in mice, a fraction of Tfh cells have the capacity to become memory cells and can promote germinal centre formation and antibody production more effectively than nonTfh cells upon antigenic challenge [91] [92] [93] [94] [95] .
Initial evidence for memory cTfh cells in humans came from studies of human malignancies [27, 28, 97] . A more comprehensive study by Morita et al. [29] further defined a population of memory Tfh-like cells with an enhanced capacity to provide naive and memory B-cell help. This study subdivided circulating Tfh-like cells into three subsets (Th1, Th2 and Th17-like) based on their expression or the lack of CXCR3 and CCR6 and demonstrated that both the Th2 and Th17-like cells (CXCR3 À
CCR6
À and CXCR3 À CCR6 þ , respectively) efficiently helped naive B cells and differentially modulated isotype switching, although Th1-like subset (CXCR3 þ ) did not provide adequate help to naive B cells (described circulating Tfh-like cell subsets are summarized in Table 1 A more recent study identified a population of memory CD4 þ CXCR5 þ T cells (CCR6 hi PD-1 hi ) that produced IL-21 and supported B cell differentiation [33] . This study found that the frequency of these cells was decreased in treatment-naive HIV-infected individuals but was recovered after ART. In addition, this study also found decreased antibody production and a reduced frequency of IL-2, IL-17 and IL-21 producing CD4 þ CXCR5 
hi PD-1 hi expression) in untreated HIV infected did not correlate with the frequencies of memory B cells or with Ig neutralizing activity. This lack of concordance between the two studies likely arises from differences in the patient samples studied as well as the markers of cTfh used.
Taken together, the use of cTfh-cell frequency and function as an indirect marker of germinal centre Tfh cells or ongoing germinal centre reactions represents a very interesting tool, but will require additional investigation in order to improve their definition and harmonize their assessment.
CONCLUSION
The past few years have witnessed considerable findings with regard to Tfh cells and HIV pathogenesis. However, it is clear that intense investigation will be needed in order to better understand the mechanisms in charge of both Tfh and cTfh cell dysfunctions during the course of HIV infection and to determine the role of these cells during HIV infection. The progressive characterization of Tfh and cTfh cells will also be highly useful to elucidate the impact of HIV infection on the generation of efficient HIV-specific B-cell responses. 
